Cargando…
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is one of the most common aggressive malignancies with increasing incidence worldwide. The oncogenic roles of transcription factors (TFs) were increasingly recognized in various cancers. This study aimed to develop a predicting signature based on TFs for th...
Autores principales: | Yang, Yanbing, Ye, Xuenian, Zhang, Haibin, Lin, Zhaowang, Fang, Min, Wang, Jian, Yu, Yuyan, Hua, Xuwen, Huang, Hongxuan, Xu, Weifeng, Liu, Ling, Lin, Zhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845592/ https://www.ncbi.nlm.nih.gov/pubmed/36685838 http://dx.doi.org/10.3389/fgene.2022.1068837 |
Ejemplares similares
-
Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023) -
Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021) -
Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021) -
Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020) -
Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)